CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 52.31% | — | — | |
| 2 | REPL | Replimune Group INC | Stock-Other | 17.28% | — | — | |
| 3 | IFRX | InflaRx N.V. | Stock-Other | 11.07% | — | -58.49% | |
| 4 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 8.43% | — | — | |
| 5 | SLDB | Solid Biosciences Inc. | Stock-Other | 7.32% | — | — | |
| 6 | ✓ | Aptinyx INC | Stock-Other | 3.60% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DRNAUSD | Dicerna Pharmaceuticals INC | +19.7% | — | Unchanged |
| 2 | REPL | Replimune Group INC | +7.6% | — | Unchanged |
| 3 | MRNSUSD | Marinus Pharmaceuticals INC | +3.5% | — | Unchanged |
| 4 | ✓ | Aptinyx INC | -9% | — | Unchanged |
| 5 | IFRX | InflaRx N.V. | -10.9% | -58.49% | Trim |
| 6 | SLDB | Solid Biosciences Inc. | -10.9% | — | Unchanged |